Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion type Assertion NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_head.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion description "[The discovery of the JAK2V617F mutation followed by the discovery of other genetic abnormalities allowed important progress in the understanding of the pathogenesis and management of myeloproliferative neoplasms (MPN)s. Classical Breakpoint cluster region-Abelson (BCR-ABL)-negative neoplasms include 3 main disorders: essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_provenance.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion evidence source_evidence_literature NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_provenance.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion SIO_000772 25486952 NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_provenance.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion wasDerivedFrom befree-2016 NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_provenance.
- NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_assertion wasGeneratedBy ECO_0000203 NP1246143.RAuDOs8M8CmvRt838NzeuMmaNWdNdIviXk4u367Ml6WgI130_provenance.